A. La-grippe-humaine, F. H5n1-en-asie-http, and O. Oie, Lignes directrices sur la prévention et le contrôle de l'influenza aviaire Organisation des Nations Unies pour l'alimentation et l'agriculture- Organisation Internationale des épizooties-Organisation Mondiale de la SantéProduction of pilot lots of inactivated influenza vaccines from reassortants derived from avian influenza viruses. Interim biosafety risk assessment Organisation Mondiale de la SantéExposures that may have put a person at risk of becoming infected with influenza A(H5N1) Organisation Mondiale de la SantéWHO guidance on development of influenza vaccine reference viruses by reverse genetics Organisation Mondiale de la SantéRecommended laboratory tests to identify avian influenza A virus in specimens from humans Organisation Mondiale de la SantéCumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHOAvian influenza, including influenza A (H5N1), in humans : WHO interim infection control guideline for health care facilities Organisation Mondiale de la Santé, Peramivir : Single Dose Prophylaxis for Flu?" Center for Biosecurity of UPMC, for a briefing on Capitol Hill, 2003.

Y. Abed, I. Hardy, Y. Li, and G. Boivin, Divergent evolution of hemagglutinin and neuraminidase genes in recent influenza A:H3N2 viruses isolated in Canada, Journal of Medical Virology, vol.224, issue.4, pp.589-595, 2002.
DOI : 10.1002/jmv.10143

D. Alexander, R. Van, and M. Pensaert, A review of avian influenza in different bird species, Veterinary Microbiology, vol.74, issue.1-2, pp.3-13, 2000.
DOI : 10.1016/S0378-1135(00)00160-7

A. Amonsin, S. Payungporn, A. Theamboonlers, R. Thanawongnuwech, S. Suradhat et al., Genetic characterization of H5N1 influenza A viruses isolated from zoo tigers in Thailand, Virology, vol.344, issue.2, pp.480-491, 2005.
DOI : 10.1016/j.virol.2005.08.032

A. Apisarnthanarak, S. Erb, I. Stephenson, J. Katz, M. Chittaganpitch et al., Seroprevalence of Anti-H5 Antibody among Thai Health Care Workers after Exposure to Avian Influenza (H5N1) in a Tertiary Care Center, Clinical Infectious Diseases, vol.40, issue.2, pp.16-24, 2005.
DOI : 10.1086/427034

A. Apisarnthanarak, R. Kitphati, K. Thongphubeth, P. Patoomanunt, P. Anthanont et al., Atypical avian influenza (H5N1), Emerg Infect Dis, vol.10, issue.7, pp.1321-1325, 2004.

M. Aymard, L. Gerentes, and N. Kessler, Place des anticorps antineuraminidase dans la protection contre la grippe. (Role for antibody to neuraminidase in protecting against influenza), La Semaine des hôpitaux de Paris, vol.75, pp.23-24, 1999.

I. Babai, Y. Barenholz, Z. Zakay-rones, E. Greenbaum, S. Samira et al., A novel liposomal influenza vaccine (INFLUSOME- VAC) containing hemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective antineuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains, Vaccine, vol.20, pp.3-4, 2001.

S. Baigent and J. Mccauley, Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture, Virus Research, vol.79, issue.1-2, pp.177-85, 2001.
DOI : 10.1016/S0168-1702(01)00272-6

S. Baigent and J. Mccauley, Influenza type A in humans, mammals and birds: Determinants of virus virulence, host-range and interspecies transmission, BioEssays, vol.176, issue.7, pp.657-71, 2003.
DOI : 10.1002/bies.10303

J. Banks, E. Speidel, and A. Dj, Characterisation of an avian influenza A virus isolated from a human : is an intermediate host necessary for the emergence of pandemic influenza viruses?Changes in the haemagglutinin and the neuraminidase genes prior to the emergence of highly pathogenic H7N1 avian influenza viruses in Italy, Archives of virology Banks J, Speidel ES Archives of virology, vol.143, issue.1465, pp.781-787, 1998.

S. Bantia, C. Arnold, C. Parker, R. Upshaw, P. Chand et al., Anti-influenza virus activity of peramivir in mice with single intramuscular injectionLa grippe humaine : aspects virologiques, épidémiologie et diagnostic virologique. (Influenza : virological aspects, epidemiology and virological diagnosis), Médecine et maladies infectieuses, pp.134-142, 2003.

J. Beigel, J. Farrar, A. Han, F. Hayden, R. Hyer et al., Avian influenza A (H5N1) infection in humans, N Engl J Med, vol.353, issue.13, pp.1374-85, 2005.

J. Bennink and T. Palmore, The promise of siRNAs for the treatment of influenza, Trends in Molecular Medicine, vol.10, issue.12, pp.571-575, 2004.
DOI : 10.1016/j.molmed.2004.10.004

A. Ben-yehuda, A. Joseph, E. Zeira, S. Even-chen, I. Louria-hayon et al., Immunogenicity and safety of a novel liposomal influenza subunit vaccine (INFLUSOME-VAC) in young adults, Journal of Medical Virology, vol.164, issue.4, pp.560-567, 2003.
DOI : 10.1002/jmv.10345

A. Boibieux, D. Bouhour, F. Biron, C. Chidiac, D. Peyramond et al., Médecine et maladies infectieusesRisk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong KongRisk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998Mechanisms of pathogenicity of influenza A (H5N1) viruses in miceIncidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from, Human Infection with an Avian H9N2 Influenza A Virus in Hong Kong, pp.193-194, 1994.

D. Cappucci, J. Johnson, D. Brugh, M. Smith, T. Jackson et al., Isolation of Avian Influenza Virus (Subtype H5N2) from Chicken Eggs during a Natural Outbreak, Avian Diseases, vol.29, issue.4, pp.1195-200, 1985.
DOI : 10.2307/1590473

I. Capua and A. Dj, Avian influenza and human health, Acta Tropica, vol.83, issue.1, pp.1-6, 2002.
DOI : 10.1016/S0001-706X(02)00050-5

M. Castrucci, I. Donatelli, L. Sidoli, G. Barigazzi, Y. Kawaoka et al., Genetic Reassortment between Avian and Human Influenza A Viruses in Italian Pigs, Virology, vol.193, issue.1, pp.503-506, 1993.
DOI : 10.1006/viro.1993.1155

P. Chan, Outbreak of Avian Influenza A(H5N1) Virus Infection in Hong Kong in 1997, Clinical Infectious Diseases, vol.34, issue.S2, pp.58-64, 2002.
DOI : 10.1086/338820

S. Ali, W. Brouillette, Y. El-kattan, and T. Lin, Syntheses and neuraminidase inhibitory activity of multisubstituted cyclopentane amide derivatives, J Med Chem, vol.47, issue.8, pp.1919-1948, 2004.

X. Cheng, J. Liu, J. He, and F. Shan, Virological and serological surveys for H9N2 subtype of influenza A virus in chickens and men in Shenzhen city, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, vol.16, issue.4, pp.319-340, 2002.

C. Cheung, L. Poon, A. Lau, W. Luk, Y. Lau et al., Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?, The Lancet, vol.360, issue.9348, pp.1831-1838, 2002.
DOI : 10.1016/S0140-6736(02)11772-7

K. Chokephaibulkit, M. Uiprasertkul, P. Puthavathana, P. Chearskul, P. Auewarakul et al., A Child With Avian Influenza A (H5N1) Infection, Thailand, pp.162-168, 2004.
DOI : 10.1097/01.inf.0000151037.25237.1e

M. Coiras, J. Aguilar, M. Galiano, C. S. Gregory, V. Lin et al., Rapid molecular analysis of the haemagglutinin gene of human influenza A H3N2 viruses isolated in Spain from 1996 to 2000, Archives of Virology, vol.146, issue.11, pp.2133-2147, 1996.
DOI : 10.1007/s007050170025

L. Hansen, R. Daems, D. Giudice, G. Rappuoli, R. De-bruijn et al., Anticipating crisis : Towards a pandemic flu vaccination strategy through alignment of public health and industrial policyClinical experience with inactivated, virosomal influenza vaccineFatal avian influenza A (H5N1) in a child presenting with diarrhea followed by comaAvian influenza A (H5N1)Oseltamivir resistance during treatment of influenza A (H5N1) infection, BMJ. British medical journal Vaccine. Vaccine N Engl J Med J Clin Virol N Engl J Med, vol.326, issue.35325, pp.1235-1240, 2003.

V. Demicheli, T. Jefferson, D. Rivetti, and J. Deeks, Prevention and early treatment of influenza in healthy adults, Vaccine, vol.18, issue.11-12, pp.11-12, 2000.
DOI : 10.1016/S0264-410X(99)00332-1

K. Deshpande, C. Naeve, and R. Webster, The neuraminidases of the virulent and avirulent A/Chicken/Pennsylvania/ 83 (H5N2) influenza a viruses: Sequence and antigenic analyses, Virology, vol.147, issue.1, pp.49-60, 1985.
DOI : 10.1016/0042-6822(85)90226-0

W. Dreitlein, J. Maratos, and J. Brocavich, Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza, Clinical Therapeutics, vol.23, issue.3, pp.327-355, 2001.
DOI : 10.1016/S0149-2918(01)80042-4

R. Dutkowski, B. Thakrar, E. Froehlich, P. Suter, C. Oo et al., Safety and Pharmacology of Oseltamivir in Clinical Use, Drug Safety, vol.163, issue.14, pp.787-801, 2003.
DOI : 10.2165/00002018-200326110-00004

J. Ellis and M. Zambon, Combined PCR-Heteroduplex Mobility Assay for Detection and Differentiation of Influenza A Viruses from Different Animal Species, Journal of Clinical Microbiology, vol.39, issue.11, pp.4097-4102, 2001.
DOI : 10.1128/JCM.39.11.4097-4102.2001

M. Enserink, AVIAN INFLUENZA: 'Pandemic Vaccine' Appears to Protect Only at High Doses, Science, vol.309, issue.5737, p.996, 2005.
DOI : 10.1126/science.309.5737.996b

M. Enserink and J. Kaiser, VIROLOGY: Avian Flu Finds New Mammal Hosts, Science, vol.305, issue.5689, p.1385, 2004.
DOI : 10.1126/science.305.5689.1385a

L. Faulkner, G. Buchan, L. Slobbe, E. Lockhart, J. Wales et al., Influenza hemagglutinin peptides fused to interferon gamma and encapsulated in liposomes protects mice against influenza infection, Vaccine, vol.21, issue.9-10, pp.9-10, 2003.
DOI : 10.1016/S0264-410X(02)00543-1

D. Fedson, Vaccination for Pandemic Influenza and Severe Acute Respiratory Syndrome: Common Issues and Concerns, Clinical Infectious Diseases, vol.36, issue.12, pp.1562-1563, 2003.
DOI : 10.1086/376761
URL : http://cid.oxfordjournals.org/cgi/content/short/36/12/1562

D. Fedson, Preparing for Pandemic Vaccination: An International Policy Agenda for Vaccine Development, Journal of Public Health Policy, vol.26, issue.1, pp.4-29, 2005.
DOI : 10.1057/palgrave.jphp.3200008

D. Fleming, Managing influenza : Amantadine, rimantadine and beyond, International journal of clinical practice : (Esher), vol.55, issue.3, pp.189-195, 2001.

R. Fouchier, V. Munster, A. Wallensten, T. Bestebroer, S. Herfst et al., Characterization of a Novel Influenza A Virus Hemagglutinin Subtype (H16) Obtained from Black-Headed Gulls, Journal of Virology, vol.79, issue.5, pp.2814-2836, 2005.
DOI : 10.1128/JVI.79.5.2814-2822.2005

R. Fouchier, P. Schneeberger, F. Rozendaal, J. Broekman, S. Kemink et al., Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome, Proceedings of the National Academy of Sciences, vol.101, issue.5, pp.1356-61, 2004.
DOI : 10.1073/pnas.0308352100

R. Gani, Potential Impact of Antiviral Drug Use during Influenza Pandemic, Emerging Infectious Diseases, vol.11, issue.9, pp.1355-62, 2005.
DOI : 10.3201/eid1209.041344

W. Gao, A. Soloff, X. Lu, A. Montecalvo, D. Nguyen et al., Protection of Mice and Poultry from Lethal H5N1 Avian Influenza Virus through Adenovirus-Based Immunization, Journal of Virology, vol.80, issue.4, pp.1959-64, 2006.
DOI : 10.1128/JVI.80.4.1959-1964.2006

Q. Ge, H. Eisen, and C. J. , Use of siRNAs to prevent and treat influenza virus infection, Virus Research, vol.102, issue.1, pp.37-42, 2004.
DOI : 10.1016/j.virusres.2004.01.013

Q. Ge, L. Filip, A. Bai, T. Nguyen, H. Eisen et al., Inhibition of influenza virus production in virus-infected mice by RNA interference, Proceedings of the National Academy of Sciences, vol.101, issue.23, pp.8676-81, 2004.
DOI : 10.1073/pnas.0402486101

M. Gibbs, J. Armstrong, and A. Gibbs, Recombination in the Hemagglutinin Gene of the 1918 "Spanish Flu", Science, vol.293, issue.5536, pp.1842-1845, 1918.
DOI : 10.1126/science.1061662

M. Girard, T. Cherian, Y. Pervikov, M. Kieny, E. Govorkova et al., A review of vaccine research and development: Human acute respiratory infections, Vaccine, vol.23, issue.50, pp.5708-5732, 2005.
DOI : 10.1016/j.vaccine.2005.07.046

C. Grose and K. Chokephaibulkit, Avian Influenza Virus Infection of Children in Vietnam and Thailand, The Pediatric Infectious Disease Journal, vol.23, issue.8, pp.793-797, 2004.
DOI : 10.1097/00006454-200408000-00024

L. Gubareva, Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors, Virus Research, vol.103, issue.1-2, pp.199-203, 2004.
DOI : 10.1016/j.virusres.2004.02.034

C. Hannoun, Sur la piste du virus de la grippe espagnole (1918-1919). (On the trail of Spanish influenza virus), Virologie : (Montrouge), vol.5, issue.1, pp.45-52, 2001.

M. Hatta, G. Peng, P. Halfmann, and Y. Kawaoka, Molecular Basis for High Virulence of Hong Kong H5N1 Influenza A Viruses, Science, vol.293, issue.5536, pp.293-1840, 2001.
DOI : 10.1126/science.1062882

F. Hayden and A. Croisier, Transmission of Avian Influenza Viruses to and between Humans, The Journal of Infectious Diseases, vol.192, issue.8, pp.1311-1315, 2005.
DOI : 10.1086/444399

M. Herlocher, R. Truscon, S. Elias, H. Yen, N. Roberts et al., Influenza Viruses Resistant to the Antiviral Drug Oseltamivir: Transmission Studies in Ferrets, The Journal of Infectious Diseases, vol.190, issue.9, pp.1627-1657, 2004.
DOI : 10.1086/424572

M. Hilleman, Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control, Vaccine, vol.20, issue.25-26, pp.25-26, 2002.
DOI : 10.1016/S0264-410X(02)00254-2

V. Hinshaw, R. Webster, B. Easterday, W. Bean, and J. , Replication of avian influenza A viruses in mammals, Infect Immun, vol.34, issue.2, pp.354-61, 1981.

M. Hoelscher, S. Garg, D. Bangari, J. Belser, X. Lu et al., Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice, The Lancet, vol.367, issue.9509, pp.475-81, 2006.
DOI : 10.1016/S0140-6736(06)68076-8

E. Hoffmann, S. Krauss, D. Perez, R. Webby, and R. Webster, Eightplasmid system for rapid generation of influenza virus vaccines, Vaccine, vol.20, pp.25-26, 2002.

E. Hoffmann, G. Neumann, Y. Kawaoka, G. Hobom, and R. Webster, A DNA transfection system for generation of influenza A virus from eight plasmids, Proceedings of the National Academy of Sciences, vol.97, issue.11, pp.6108-6121, 2000.
DOI : 10.1073/pnas.100133697

T. Horimoto and Y. Kawaoka, Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus, Journal of virology, vol.68, issue.5, pp.3120-3128, 1994.

T. Horimoto, A. Takada, K. Fujii, H. Goto, M. Hatta et al., The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate, Vaccine, vol.24, issue.17, 2005.
DOI : 10.1016/j.vaccine.2005.07.005

C. Hualan, K. Subbarao, D. Swayne, C. Qi, L. Xiuhua et al., Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate, Vaccine, vol.21, pp.17-18, 2003.

J. Wilschut, Influenza vaccines: The virosome concept, Immunology Letters, vol.122, issue.2, pp.26-38, 2005.
DOI : 10.1016/j.imlet.2008.11.006

D. Hulse, R. Webster, R. Russell, and D. Perez, Molecular Determinants within the Surface Proteins Involved in the Pathogenicity of H5N1 Influenza Viruses in Chickens, Journal of Virology, vol.78, issue.18, pp.9954-64, 2004.
DOI : 10.1128/JVI.78.18.9954-9964.2004

N. Ilyushina, E. Govorkova, and R. Webster, Detection of amantadine-resistant variants among avian influenza viruses isolated in North America and Asia, Virology, vol.341, issue.1, pp.102-108, 2005.
DOI : 10.1016/j.virol.2005.07.003

J. Gnann and J. , Données sur la grippe à virus A (H5N1) à Hong Kong et sur le début de grippe à virus A (H3N2) en France, Bulletin Epidemiologique Hebdomadaire, vol.8

M. Elliott, H. Weiss, and F. Hayden, Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza, Antivir Ther, vol.8, issue.3, pp.183-90, 2003.

T. Iwasaki, S. Itamura, H. Nishimura, Y. Sato, M. Tashiro et al., Productive infection in the murine central nervous system with avian influenza virus A (H5N1) after intranasal inoculation, Acta Neuropathologica, vol.139, issue.6, pp.485-92, 2004.
DOI : 10.1007/s00401-004-0909-0

H. Izurieta, P. Haber, R. Wise, J. Iskander, D. Pratt et al., Adverse Events Reported Following Live, Cold-Adapted, Intranasal Influenza Vaccine, JAMA, vol.294, issue.21, pp.2720-2725, 2005.
DOI : 10.1001/jama.294.21.2720

L. Kaiser, Inhibiteurs de la neuraminidase et traitement de la grippe : un bénéfice au-delà de la résolution des symptômes ? : Maladies infectieuses. (Treatment of Influenza with neuraminidase inhibitors : is there a benefit beyoud symptom resolution ?), Médecine et hygiène, vol.593, pp.2296-2300, 2001.

M. Kaji, T. Fukuda, M. Tanaka, and H. Aizawa, A side effect of neuraminidase inhibitor in a patient with liver cirrhosis, Journal of Infection and Chemotherapy, vol.11, issue.1, pp.41-44, 2005.
DOI : 10.1007/s10156-004-0358-7

F. Karcher and H. Buchow, Plan de préparation et réponse à la pandémie de grippe au niveau de la Communauté européenne, Eurosurveillance -Bulletin Europeen Sur Les Maladies Transmissibles, vol.7, issue.11, pp.166-168, 2002.

Y. Kawaoka, S. Krauss, and R. Webster, Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics, Journal of Virology, vol.63, issue.11, pp.4603-4608, 1989.

J. Keawcharoen, K. Oraveerakul, T. Kuiken, R. Fouchier, A. Amonsin et al., Avian Influenza H5N1 in Tigers and Leopards, Emerging Infectious Diseases, vol.10, issue.12, pp.2189-91, 2004.
DOI : 10.3201/eid1012.040759

H. Kida, T. Ito, J. Yasuda, Y. Shimizu, C. Itakura et al., Potential for transmission of avian influenza viruses to pigs, Journal of General Virology, vol.75, issue.9, pp.2183-2188, 1994.
DOI : 10.1099/0022-1317-75-9-2183

M. Kiso, K. Mitamura, Y. Sakai-tagawa, K. Shiraishi, C. Kawakami et al., Resistant influenza A viruses in children treated with oseltamivir: descriptive study, The Lancet, vol.364, issue.9436, pp.759-65, 2004.
DOI : 10.1016/S0140-6736(04)16934-1

D. Kobasa, S. Kodihalli, M. Luo, M. Castrucci, I. Donatelli et al., Amino acid residues contributing to the substrate specificity of the influenza A virus neuraminidase, J Virol, vol.73, issue.8, pp.6743-51, 1999.

D. Kobasa, A. Takada, K. Shinya, M. Hatta, P. Halfmann et al., Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus, Nature, vol.27, issue.7009, pp.703-710, 2004.
DOI : 10.1093/glycob/cwg032

M. Koopmans, B. Wilbrink, M. Conyn, G. Natrop, H. Van-der-nat et al., Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands, The Lancet, vol.363, issue.9409, pp.587-93, 2004.
DOI : 10.1016/S0140-6736(04)15589-X

T. Kuiken, G. Rimmelzwaan, D. Van-riel, G. Van-amerongen, M. Baars et al., Avian H5N1 Influenza in Cats, Science, vol.306, issue.5694, p.241, 2004.
DOI : 10.1126/science.1102287

G. Laver and E. Garman, Pandemic influenza: its origin and control, Microbes and Infection, vol.4, issue.13, pp.1309-1316, 2002.
DOI : 10.1016/S1286-4579(02)00013-8

Q. Le, M. Kiso, K. Someya, Y. Sakai, T. Nguyen et al., Avian flu: Isolation of drug-resistant H5N1 virus, Nature, vol.11, issue.7062, p.1108, 2005.
DOI : 10.1128/JVI.79.15.9926-9932.2005

H. and A. Kong, The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A, Antiviral research, vol.1569799, issue.482, pp.101-115, 1074.

K. Li, Y. Guan, J. Wang, G. Smith, K. Xu et al., Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia, Nature, vol.47, issue.6996, pp.209-222, 2004.
DOI : 10.1093/bioinformatics/17.12.1244

S. Li, M. Perdue, E. Patzer, F. Brown, and I. Gust, Seed viruses containing novel avian HA and NA antigens for prevention against potential influenza pandemic, Developments in biologicals, vol.110, pp.135-141, 2002.

Y. Li, Z. Lin, J. Shi, Q. Qi, G. Deng et al., Detection of Hong Kong 97-like H5N1 influenza viruses from eggs of Vietnamese waterfowl, Archives of Virology, vol.73, issue.8, 2006.
DOI : 10.1007/s00705-006-0738-7

Z. Li, H. Chen, P. Jiao, G. Deng, G. Tian et al., Molecular Basis of Replication of Duck H5N1 Influenza Viruses in a Mammalian Mouse Model, Journal of Virology, vol.79, issue.18, pp.12058-64, 2005.
DOI : 10.1128/JVI.79.18.12058-12064.2005

N. Liem and W. Lim, Lack of H5N1 Avian Influenza Transmission to Hospital Employees, Hanoi, 2004, Emerging Infectious Diseases, vol.11, issue.2, pp.210-215, 2004.
DOI : 10.3201/eid1102.041075

Y. Lin, M. Shaw, V. Gregory, K. Cameron, W. Lim et al., Avian-to-human transmission of H9N2 subtype influenza A viruses: Relationship between H9N2 and H5N1 human isolates, Proceedings of the National Academy of Sciences, vol.97, issue.17, pp.97-9654, 2000.
DOI : 10.1073/pnas.160270697

S. Lindstrom, N. Cox, and A. Klimov, Genetic analysis of human H2N2 and early H3N2 influenza viruses, 1957???1972: evidence for genetic divergence and multiple reassortment events, Virology, vol.328, issue.1, pp.101-120, 2004.
DOI : 10.1016/j.virol.2004.06.009

A. Lipatov, S. Andreansky, R. Webby, D. Hulse, J. Rehg et al., Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses, Journal of General Virology, vol.86, issue.4, pp.1121-1151, 2005.
DOI : 10.1099/vir.0.80663-0

C. Luke and K. Subbarao, Vaccines for Pandemic Influenza, Emerging Infectious Diseases, vol.12, issue.1, 2006.
DOI : 10.3201/eid1201.051147

M. Luscher-mattli, Influenza chemotherapy: a review of the present state of art and of new drugs in development, Archives of Virology, vol.145, issue.11, pp.2233-2248, 2000.
DOI : 10.1007/s007050070017

S. Macdonald, R. Cameron, D. Demaine, R. Fenton, G. Foster et al., Dimeric Zanamivir Conjugates with Various Linking Groups Are Potent, Long-Lasting Inhibitors of Influenza Neuraminidase Including H5N1 Avian Influenza, Journal of Medicinal Chemistry, vol.48, issue.8, pp.2964-71, 2005.
DOI : 10.1021/jm040891b

S. Macdonald, K. Watson, R. Cameron, D. Chalmers, D. Demaine et al., Potent and Long-Acting Dimeric Inhibitors of Influenza Virus Neuraminidase Are Effective at a Once-Weekly Dosing Regimen, Antimicrobial Agents and Chemotherapy, vol.48, issue.12, pp.4542-4551, 2004.
DOI : 10.1128/AAC.48.12.4542-4549.2004

T. Maines, X. Lu, S. Erb, L. Edwards, J. Guarner et al., Avian Influenza (H5N1) Viruses Isolated from Humans in Asia in 2004 Exhibit Increased Virulence in Mammals, Journal of Virology, vol.79, issue.18, pp.11788-800, 2005.
DOI : 10.1128/JVI.79.18.11788-11800.2005

G. Marsh and G. Tannock, The role of reverse genetics in the development of vaccines against respiratory viruses, Expert Opinion on Biological Therapy, vol.22, issue.5, pp.369-80, 2005.
DOI : 10.1128/JVI.74.7.3188-3195.2000

H. Masuda, H. Suzuki, H. Oshitani, R. Saito, S. Kawasaki et al., Incidence of Amantadine-Resistant Influenza A Viruses in Sentinel Surveillance Sites and Nursing Homes in Niigata, Japan, Microbiology and Immunology, vol.180, issue.rr-3, pp.833-839, 2000.
DOI : 10.1111/j.1348-0421.2000.tb02571.x

K. Mcclellan and C. Perry, Oseltamivir, Drugs, vol.171, issue.9, pp.263-283, 2001.
DOI : 10.2165/00003495-200161020-00011

A. Mcgeer, W. Lee, M. Loeb, A. Simor, M. Mcarthur et al., Conclusions:, Infection Control & Hospital Epidemiology, vol.15, issue.11, pp.955-61, 2004.
DOI : 10.2165/00002512-199405010-00002

J. Mckimm-breschkin, Management of Influenza Virus Infections with Neuraminidase Inhibitors, Treatments in Respiratory Medicine, vol.19, issue.9, pp.107-123, 2005.
DOI : 10.2165/00151829-200504020-00004

I. Mcnicholl and J. Mcnicholl, Neuraminidase Inhibitors: Zanamivir and Oseltamivir, The) Annals of pharmacotherapy, pp.57-70, 2001.
DOI : 10.1345/aph.10118

A. Meijer, M. Valette, J. Manuguerra, P. Perez-brena, J. Paget et al., Implementation of the Community Network of Reference Laboratories for Human Influenza in Europe, Journal of Clinical Virology, vol.34, issue.2, pp.87-96, 2005.
DOI : 10.1016/j.jcv.2005.02.005

V. Mishin, F. Hayden, and L. Gubareva, Susceptibilities of Antiviral-Resistant Influenza Viruses to Novel Neuraminidase Inhibitors, Antimicrobial Agents and Chemotherapy, vol.49, issue.11, pp.4515-4535, 2005.
DOI : 10.1128/AAC.49.11.4515-4520.2005

A. Monto, A. Osterhaus, A. Palache, J. Peiris, V. Savy et al., The role of antivirals in the control of influenza, Vaccine, vol.21, issue.16, pp.1796-1800, 2003.
DOI : 10.1016/S0264-410X(03)00075-6

A. Moscona, Neuraminidase Inhibitors for Influenza, New England Journal of Medicine, vol.353, issue.13, pp.1363-73, 2005.
DOI : 10.1056/NEJMra050740

A. Mounts, H. Kwong, H. Izurieta, Y. Ho, T. Au et al., Case???Control Study of Risk Factors for Avian Influenza A (H5N1) Disease, Hong Kong, 1997, The Journal of Infectious Diseases, vol.180, issue.2, pp.505-513, 1997.
DOI : 10.1086/314903

G. Neumann, K. Fujii, Y. Kino, and Y. Kawaoka, An improved reverse genetics system for influenza A virus generation and its implications for vaccine production, Proceedings of the National Academy of Sciences, vol.102, issue.46, pp.16825-16834, 2005.
DOI : 10.1073/pnas.0505587102

G. Neumann, T. Watanabe, H. Ito, S. Watanabe, H. Goto et al., Generation of influenza A viruses entirely from cloned cDNAs, Proceedings of the National Academy of Sciences, vol.96, issue.16, pp.96-9345, 1999.
DOI : 10.1073/pnas.96.16.9345

G. Neumann, M. Whitt, and Y. Kawaoka, A decade after the generation of a negative-sense RNA virus from cloned cDNA ??? what have we learned?, Journal of General Virology, vol.83, issue.11, pp.2635-62, 2002.
DOI : 10.1099/0022-1317-83-11-2635

E. Ng, P. Cheng, A. Ng, T. Hoang, and W. Lim, Influenza A H5N1 Detection, Emerging Infectious Diseases, vol.11, issue.8, pp.1303-1308, 2005.
DOI : 10.3201/eid1108.041317

K. Nicholson, A. Colegate, A. Podda, L. Stephenson, J. Wood et al., Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza, The Lancet, vol.357, issue.9272, pp.357-1937, 2001.
DOI : 10.1016/S0140-6736(00)05066-2

C. Nicolson, D. Major, J. Wood, and J. Robertson, Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system, Vaccine, vol.23, issue.22, pp.2943-52, 2005.
DOI : 10.1016/j.vaccine.2004.08.054

D. Noah and R. Krug, Influenza Virus Virulence and Its Molecular Determinants, Adv Virus Res, vol.65, pp.121-166, 2005.
DOI : 10.1016/S0065-3527(05)65004-X

B. Nordstrom, K. Oh, S. Sacks, L. Italien, and G. , Skin reactions in patients with influenza treated with oseltamivir : a retrospective cohort study, Antivir Ther, vol.9, issue.2, pp.187-95, 2004.

N. Nwe, Q. He, S. Damrongwatanapokin, Q. Du, I. Manopo et al., Expression of hemagglutinin protein from the avian influenza virus H5N1 in a baculovirus/insect cell system significantly enhanced by suspension culture, BMC Microbiology, vol.6, issue.1, p.16, 2006.
DOI : 10.1186/1471-2180-6-16

S. Olsen, K. Ungchusak, L. Sovann, T. Uyeki, S. Dowell et al., Family Clustering of Avian Influenza A (H5N1), Emerging Infectious Diseases, vol.11, issue.11, pp.1799-1801, 2005.
DOI : 10.3201/eid1111.050646

J. Oxford, Oseltamivir in the management of influenza, Expert Opinion on Pharmacotherapy, vol.435, issue.14, pp.2493-500, 2005.
DOI : 10.1086/422646

J. Oxford, S. Bossuyt, S. Balasingam, A. Mann, P. Novelli et al., Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors, Clinical Microbiology and Infection, vol.9, issue.1, pp.1-14, 2003.
DOI : 10.1046/j.1469-0691.2003.00564.x

W. Paget and J. Aguilera, Les plans de lutte contre la pandémie de grippe en Europe. (Influenza pandemic planning in Europe), Euro surveillance, vol.6, issue.9, pp.136-140, 2001.

C. Parrish and Y. Kawaoka, THE ORIGINS OF NEW PANDEMIC VIRUSES: The Acquisition of New Host Ranges by Canine Parvovirus and Influenza A Viruses, Annual Review of Microbiology, vol.59, issue.1, pp.553-86, 2005.
DOI : 10.1146/annurev.micro.59.030804.121059

S. Payungporn, S. Chutinimitkul, A. Chaisingh, S. Damrongwantanapokin, C. Buranathai et al., Single step multiplex real-time RT-PCR for H5N1 influenza A virus detection, Journal of Virological Methods, vol.131, issue.2, pp.143-147, 2006.
DOI : 10.1016/j.jviromet.2005.08.004

M. Peiris, K. Yuen, C. Leung, K. Chan, P. Ip et al., Human infection with influenza H9N2, The Lancet, vol.354, issue.9182, pp.916-923, 1999.
DOI : 10.1016/S0140-6736(99)03311-5

M. Perdue, D. Suarez, R. Van, and M. Pensaert, Structural features of the avian influenza virus hemagglutinin that influence virulence, Veterinary Microbiology, vol.74, issue.1-2, pp.77-86, 2000.
DOI : 10.1016/S0378-1135(00)00168-1

E. Playford and D. Dwyer, Laboratory diagnosis of influenza virus infection, Pathology, vol.34, issue.2, pp.115-125, 2002.
DOI : 10.1080/003130201201117909

P. Puthavathana, P. Auewarakul, P. Charoenying, K. Sangsiriwut, P. Pooruk et al., Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand, Journal of General Virology, vol.86, issue.2, pp.423-456, 2005.
DOI : 10.1099/vir.0.80368-0

S. Puzelli, D. Trani, L. Fabiani, C. Campitelli, L. et al., Serological Analysis of Serum Samples from Humans Exposed to Avian H7 Influenza Viruses in Italy between 1999 and 2003, The Journal of Infectious Diseases, vol.192, issue.8, pp.1318-1340, 1999.
DOI : 10.1086/444390

G. Rimmelzwaan, T. Kuiken, G. Van-amerongen, T. Bestebroer, R. Fouchier et al., A Primate Model to Study the Pathogenesis of Influenza A (H5N1) Virus Infection, Avian Diseases, vol.47, issue.s3, pp.931-934, 2003.
DOI : 10.1637/0005-2086-47.s3.931

N. Roberts, Anti-influenza drugs and neuraminidase inhibitors, Progress in drug research, vol.56, pp.195-237, 2001.
DOI : 10.1007/978-3-0348-8319-1_5

T. Rowe, R. Abernathy, J. Hu-primmer, W. Thompson, X. Lu et al., Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays, J Clin Microbiol, vol.37, issue.4, pp.937-980, 1999.

T. Rowe, D. Cho, R. Bright, L. Zitzow, and J. Katz, Neurological Manifestations of Avian Influenza Viruses in Mammals, Avian Diseases, vol.47, issue.s3, pp.1122-1128, 2003.
DOI : 10.1637/0005-2086-47.s3.1122

C. Russell and R. Webster, The Genesis of a Pandemic Influenza Virus, Cell, vol.123, issue.3, pp.368-71, 2005.
DOI : 10.1016/j.cell.2005.10.019

A. Savarino, Expanding the frontiers of existing antiviral drugs: Possible effects of HIV-1 protease inhibitors against SARS and avian influenza, Journal of Clinical Virology, vol.34, issue.3, pp.170-178, 2005.
DOI : 10.1016/j.jcv.2005.03.005

C. Schultsz, V. Dong, N. Chau, N. Le, W. Lim et al., Avian Influenza H5N1 and Healthcare Workers, Emerging Infectious Diseases, vol.11, issue.7, pp.1158-1167, 2005.
DOI : 10.3201/eid1107.050070
URL : http://doi.org/10.3201/eid1107.050070

S. Seo, E. Hoffmann, and R. Webster, Lethal H5N1 influenza viruses escape host anti-viral cytokine responses, Nature Medicine, vol.8, issue.9, pp.950-954, 2002.
DOI : 10.1128/JVI.76.9.4420-4429.2002

S. Seo, E. Hoffmann, and R. Webster, RETRACTED: The NS1 gene of H5N1 influenza viruses circumvents the host anti-viral cytokine responses, Virus Research, vol.103, issue.1-2, pp.107-120, 2004.
DOI : 10.1016/j.virusres.2004.02.022

L. Shengqiang, L. Chongguang, A. Klimov, K. Subbarao, M. Perdue et al., Recombinant influenza A virus vaccines for the pathogenic human A, H5N1) viruses, pp.1132-1138, 1999.

K. Shinya, S. Hamm, M. Hatta, H. Ito, T. Ito et al., PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice, Virology, vol.320, issue.2, pp.258-66, 2004.
DOI : 10.1016/j.virol.2003.11.030

K. Shinya, M. Hatta, S. Yamada, A. Takada, S. Watanabe et al., Characterization of a Human H5N1 Influenza A Virus Isolated in 2003, Journal of Virology, vol.79, issue.15, pp.9926-9958, 2005.
DOI : 10.1128/JVI.79.15.9926-9932.2005

R. Sidwell, K. Bailey, M. Wong, D. Barnard, and D. Smee, In vitro and in vivo influenza virus-inhibitory effects of viramidine, Antiviral Research, vol.68, issue.1, pp.10-17, 2005.
DOI : 10.1016/j.antiviral.2005.06.003

L. Sims, J. Domenech, C. Benigno, S. Kahn, A. Kamata et al., Origin and evolution of highly pathogenic H5N1 avian influenza in Asia, Veterinary Record, vol.157, issue.6, pp.159-64, 2005.
DOI : 10.1136/vr.157.6.159

A. Stegeman, A. Bouma, A. Elbers, M. De-jong, G. Nodelijk et al., Avian Influenza A Virus (H7N7) Epidemic in The Netherlands in 2003: Course of the Epidemic and Effectiveness of Control Measures, The Journal of Infectious Diseases, vol.190, issue.12, pp.2088-95, 2004.
DOI : 10.1086/425583

I. Stephenson, K. Nicholson, A. Colegate, A. Podda, J. Wood et al., Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population, Vaccine, vol.21, issue.15, pp.1687-93, 2003.
DOI : 10.1016/S0264-410X(02)00632-1

I. Stephenson, J. Wood, K. Nicholson, and M. Zambon, Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin, Journal of Medical Virology, vol.21, issue.3, pp.391-399, 2003.
DOI : 10.1002/jmv.10408

R. Strikas, G. Wallace, and M. Myers, Influenza Pandemic Preparedness Action Plan for the United States: 2002 Update, Clinical Infectious Diseases, vol.35, issue.5, pp.590-596, 2002.
DOI : 10.1086/342200

D. Suarez, R. Van, and M. Pensaert, Evolution of avian influenza viruses, Veterinary Microbiology, vol.74, issue.1-2, pp.15-27, 2000.
DOI : 10.1016/S0378-1135(00)00161-9

K. Subbarao, H. Chen, D. Swayne, L. Mingay, E. Fodor et al., Evaluation of a Genetically Modified Reassortant H5N1 Influenza A Virus Vaccine Candidate Generated by Plasmid-Based Reverse Genetics, Virology, vol.305, issue.1, pp.192-200, 2003.
DOI : 10.1006/viro.2002.1742

C. Sun, H. Huang, M. Feng, X. Shi, X. Zhang et al., A novel class of potent influenza virus inhibitors: Polysubstituted acylthiourea and its fused heterocycle derivatives, Bioorganic & Medicinal Chemistry Letters, vol.16, issue.1, pp.162-168, 2006.
DOI : 10.1016/j.bmcl.2005.09.033

Y. Suzuki, Host Mediated Variation and Receptor Binding Specificity of Influenza Viruses, Adv Exp Med Biol, vol.491, pp.445-51, 2001.
DOI : 10.1007/978-1-4615-1267-7_29

Y. Suzuki, Sialobiology of Influenza: Molecular Mechanism of Host Range Variation of Influenza Viruses, Biological and Pharmaceutical Bulletin, vol.28, issue.3, pp.399-408, 2005.
DOI : 10.1248/bpb.28.399

Y. Suzuki, T. Ito, T. Suzuki, R. Holland, . Jr et al., Sialic Acid Species as a Determinant of the Host Range of Influenza A Viruses, Journal of Virology, vol.74, issue.24, pp.11825-11856, 2000.
DOI : 10.1128/JVI.74.24.11825-11831.2000

H. Tanaka, C. Park, A. Ninomiya, H. Ozaki, A. Takada et al., Neurotropism of the 1997 Hong Kong H5N1 influenza virus in mice, Veterinary Microbiology, vol.95, issue.1-2, pp.1-13, 2003.
DOI : 10.1016/S0378-1135(03)00132-9

J. Taubenberger, A. Reid, R. Lourens, R. Wang, J. G. Fanning et al., Characterization of the 1918 influenza virus polymerase genes, Nature, vol.437, issue.7060, pp.889-93, 2005.
DOI : 10.1038/nature04230

R. Thanawongnuwech, A. Amonsin, R. Tantilertcharoen, S. Damrongwatanapokin, A. Theamboonlers et al., Probable Tiger-to-Tiger Transmission of Avian Influenza H5N1, Emerging Infectious Diseases, vol.11, issue.5, pp.699-701, 2005.
DOI : 10.3201/eid1105.050007

M. Thornley, Avian influenza ravages Thai tigers, Australian Veterinary Journal, vol.82, issue.11, p.652, 2004.
DOI : 10.1111/j.1751-0813.2004.tb12130.x

S. Tompkins, C. Lo, T. Tumpey, and S. Epstein, Protection against lethal influenza virus challenge by RNA interference in vivo, Proceedings of the National Academy of Sciences, vol.101, issue.23, pp.8682-8688, 2004.
DOI : 10.1073/pnas.0402630101

T. Tran, T. Nguyen, T. Nguyen, T. Luong, P. Pham et al., Avian influenza A (H5N1) in 10 patients in Vietnam, N Engl J Med, vol.350, issue.12, pp.1179-88, 2004.

J. Treanor, B. Wilkinson, F. Masseoud, J. Hu-primmer, R. Battaglia et al., Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans, Vaccine, vol.19, issue.13-14, pp.13-14, 2001.
DOI : 10.1016/S0264-410X(00)00395-9

T. Tumpey, C. Basler, P. Aguilar, H. Zeng, A. Solorzano et al., Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus, Science, vol.310, issue.5745, pp.77-80, 2005.
DOI : 10.1126/science.1119392

K. Ungchusak, P. Auewarakul, S. Dowell, R. Kitphati, W. Auwanit et al., Probable Person-to-Person Transmission of Avian Influenza A (H5N1), New England Journal of Medicine, vol.352, issue.4, pp.333-373, 2005.
DOI : 10.1056/NEJMoa044021

T. Uyeki, Y. Chong, J. Katz, W. Lim, Y. Ho et al., Lack of Evidence for Human-to-Human Transmission of Avian Influenza A (H9N2) Viruses in Hong Kong, China 1999, Emerging Infectious Diseases, vol.8, issue.2, pp.154-163, 1999.
DOI : 10.3201/eid0802.010148

D. Van and J. Manuguerra, Bases moléculaires de la variabilité et diffusion des virus grippaux. (Molecular basis of influenza virus variability and diffusion), Eurobiologiste : (Paris), vol.34, issue.247, pp.38-41, 2000.

J. Wales, M. Baird, N. Davies, and G. Buchan, Fusing subunit antigens to interleukin-2 and encapsulating them in liposomes improves their antigenicity but not their protective efficacy, Vaccine, vol.23, issue.17-18, pp.17-18, 2005.
DOI : 10.1016/j.vaccine.2005.01.040

J. Walker and Y. Kawaoka, Importance of conserved amino acids at the cleavage site of the haemagglutinin of a virulent avian influenza A virus, Journal of General Virology, vol.74, issue.2, pp.311-314, 1993.
DOI : 10.1099/0022-1317-74-2-311

P. Ward, I. Small, J. Smith, P. Suter, and R. Dutkowski, Oseltamivir (Tamiflu(R)) and its potential for use in the event of an influenza pandemic, Journal of Antimicrobial Chemotherapy, vol.55, issue.suppl_1, pp.5-21, 2005.
DOI : 10.1093/jac/dki018

K. Watson, R. Cameron, R. Fenton, D. Gower, S. Hamilton et al., Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase, Bioorganic & Medicinal Chemistry Letters, vol.14, issue.6, pp.1589-92, 2004.
DOI : 10.1016/j.bmcl.2003.09.102

R. Webby, D. Perez, J. Coleman, Y. Guan, J. Knight et al., Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines, The Lancet, vol.363, issue.9415, pp.1099-103, 2004.
DOI : 10.1016/S0140-6736(04)15892-3

V. Wiwanitkit, Diarrhoea as a presentation of bird flu infection: a summary on its correlation to outcome in Thai cases, Gut, vol.54, issue.10, p.1506, 2005.
DOI : 10.1136/gut.2005.072488

X. Xu, S. Lindstrom, M. Shaw, C. Smith, H. Hall et al., Reassortment and evolution of current human influenza A and B viruses, Virus Research, vol.103, issue.1-2, pp.55-60, 2004.
DOI : 10.1016/j.virusres.2004.02.013

H. Yen, L. Herlocher, E. Hoffmann, M. Matrosovich, A. Monto et al., Neuraminidase Inhibitor-Resistant Influenza Viruses May Differ Substantially in Fitness and Transmissibility, Antimicrobial Agents and Chemotherapy, vol.49, issue.10, pp.4075-84, 2005.
DOI : 10.1128/AAC.49.10.4075-4084.2005

H. Yen, A. Monto, R. Webster, and E. Govorkova, Virulence May Determine the Necessary Duration and Dosage of Oseltamivir Treatment for Highly Pathogenic A/Vietnam/1203/04 Influenza Virus in Mice, The Journal of Infectious Diseases, vol.192, issue.4, pp.665-72, 2005.
DOI : 10.1086/432008

K. Yuen and S. Wong, Human infection by avian influenza A H5N1, Hong Kong Med J, vol.11, issue.3, pp.189-99, 2005.

M. Zambon, The pathogenesis of influenza in humans, Reviews in Medical Virology, vol.56, issue.4, pp.227-241, 2001.
DOI : 10.1002/rmv.319

R. Zurbriggen, Immunostimulating reconstituted influenza virosomes, Vaccine, vol.21, issue.9-10, pp.921-925, 2003.
DOI : 10.1016/S0264-410X(02)00541-8